Abstract
OBJECTIVE: To compare the clinical importance (association with illness severity and survival) of depressive and HIV symptoms among veterans with HIV infection.
DESIGN: Cross-sectional study; survival analysis.
SETTING: Infectious Disease Clinics at 3 VA Medical Centers.
PARTICIPANTS: HIV-infected patients (N=881) and their health care providers from June 1999 through July 2000.
MEASUREMENTS AND MAIN RESULTS: Depressive symptoms were assessed using the 10-item Centers for Epidemiologic Studies Depression Scale (CES-D). Patient baseline survey included an HIV Symptom Index measuring the frequency and bother of 20 common symptoms. Providers were surveyed on patients’ illness severity, and survival data were obtained from VA death records. Of 881 patients, 46% had significant depressive symptoms (CES-D ≥10). Increasing depression symptom severity was associated with increasing HIV symptom frequency (P<.001) and bother (P<.001). Multiple regression results revealed that having moderate or severe depressive symptoms was not associated with provider-reported illness severity or survival. However, HIV symptoms were significantly associated with provider-reported illness severity (P<.01) and survival (P=.05), after adjusting for moderate and severe depressive symptoms, CD4 cell count/mm3, viral load, age, race, and antiretroviral use.
CONCLUSIONS: Depression, while common in this sample, was not associated with illness severity or mortality after adjusting for HIV symptoms. HIV symptoms are associated with severity of illness and survival regardless of patients’ severity of depressive symptoms. This suggests that equal medical consideration should be given to HIV symptoms presented by HIV-infected patients regardless of their depression status, rather than automatically attributing medical complaints to depression.
Similar content being viewed by others
References
Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188:662–70.
Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol. 1996;31:212–9.
Lyketsos CG, Hoover DR, Guccione M, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996;153:1430–7.
Griffin KW, Rabkin JG, Remien RH, Williams JB. Disease severity, physical limitations and depression in HIV-infected men. J Psychosom Res. 1998;44:219–27.
Hoover DR, Saah AJ, Bacellar H, et al. Signs and symptoms of “asymptomatic” HIV-1 infection in homosexual men. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1993;6:66–71.
Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr. 1999;21:126–33.
Justice AC, Chang CH, Rabeneck L, Zackin R. Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care. 2001;39:397–408.
Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med. 2001;134:854–60.
Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med. 1998;104:129–36.
Wilson IB, Cleary PD. Clinical predictors of declines in physical functioning in persons with AIDS: results of a longitudinal Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:343–9.
Wilson IB, Roubenoff R, Knox TA, Spiegelman D, Gorbach SL. Relation of lean body mass to health-related quality of life in persons with HIV. J Acquir Immune Defic Syndr. 2000;24:137–46.
Wheeler DA, Gilbert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn community programs for clinical research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:80–5.
Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466–74.
Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. JAMA. 1993;270:2563–7.
Lyketsos CG, Federman EB. Psychiatric disorders and HIV infection: impact on one another. Epidemiol Rev. 1995;17:152–64.
Rabkin JG, Goetz RR, Remien RH, Williams JB, Todak G, Gorman JM. Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatry. 1997;154:231–8.
Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568–73.
Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397–406.
Graber MA, Bergus G, Dawson JD, Wood GB, Levy BT, Levin I. Effect of a patient’s psychiatric history on physicians’ estimation of probability of disease. J Gen Intern Med. 2000;15:204–6.
Smola S, Justice AC, Wagner J, Rabeneck L, Weissman S, Rodriguez-Barradas M. Veterans aging cohort three-site study (VACS 3): overview and description. J Clin Epidemiol. 2001;54(suppl 1):61–76.
Andresen EM, Carter WB, Malmgren JA, Patrick DK. Screening for depression in well older adults: evaluation of a short form of the CES-D. Am J Prev Med. 1994;10:77–84.
Low-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23:295–301.
Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122:913–21.
Zich JM, Attkisson CC, Greenfield TK. Screening for depression in primary care clinics: the CESD and the BDI. Int J Psychiatry Med. 1990;20:259–77.
Symptom Index HIV. AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Disease. Available at: http://www.fstrf.org/qol/adult_ql.html. Accessed May 8, 2002.
Justice AC, Holmes W, Gifford AL, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;54(suppl 1):77–90.
Charlson ME, Sax FL, MacKenzie R, Fields SD, Braham RL, Douglas RG. Assessing illness severity: does clinical judgment work? J Chronic Dis. 1986;39:439–52.
Knaus WA, Harrell FE, Lynn J, et al. The SUPPORT prognostic model: objective assessments of survival for seriously ill hospitalized adults. Ann Intern Med. 1995;122:191–203.
McKlish DK, Powell SH. How well can physicians estimate mortality in a medical intensive care unit? Med Decis Making. 1989;9:125–32.
Fisher SG, Weber L, Goldberg J, et al. Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol. 1995;141:242–50.
Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modeling strategies for improved prognostic prediction. Stat Med. 1984;3:143–52.
Office of Quality and Performance, Veterans Health Administration and the Health Quality Assessment Project, Center for Health Quality, Outcomes and Economic Research. Health Status and Outcomes of Veterans: Physical and Mental Component Summary Scores: Veterans SF-36 1999 Large Health Survey of Veteran Enrollees Executive Report. Washington, DC: Department of Veterans Affairs; 2000.
Druss BG, Rosenheck RA. Locus of mental health treatment in an integrated service system. Psychiatr Serv. 2000;51:890–2.
Kroenke K, Spitzer RL, Williams JB, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774–9.
Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134:917–25.
Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996;10:1033–9.
Sherbourne CD, Hays RD, Fleishman J, et al. Impact of psychiatric condition on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–54.
Gerber PD, Barrett JE, Barrett JA, et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med. 1992;7:170–3.
Mechanic D. Effects of psychological distress on perceptions of physical health and use of medical and psychiatric facilities. J Human Stress. 1978;4:26–32.
Suh T, Gallo JJ. Symptom profiles of depression among general medical service users compared with specialty mental health service users. Psychol Med. 1997;27:1051–63.
Hahn SR, Kroenke K, Spitzer RL, et al. The difficult patient: prevalence, psychopathology, and functional impairment. J Gen Intern Med. 1996;11:1–8.
Bangsberg DR, Moss A. When should we delay highly active antiretroviral therapy? J Gen Intern Med. 1999;14:446–8.
Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence-United States, 1996. Morb Mortal Wkly Rep. 1997;46:165–73.
Author information
Authors and Affiliations
Corresponding author
Additional information
The primary funding sources were from a National Institute of Aging (NIA) Career Development Award, a Robert Wood Johnson Faculty Scholar Award, and an Inter-agency Agreement between the NIA, National Institute of Mental Health, and the Department of Veterans Affairs (Dr. Justice, Pl). Dr. Rabeneck is the recipient of a VA Health Services Research and Development Advanced Research Career Development Award.
Rights and permissions
About this article
Cite this article
Kilbourne, A.M., Justice, A.C., Rollman, B.L. et al. Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J GEN INTERN MED 17, 512–520 (2002). https://doi.org/10.1046/j.1525-1497.2002.10803.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2002.10803.x